Inventor · disambiguated record
Jonathan Hill
Also filed as: HILL JONATHAN · HILL JONATHAN M
10 granted patents·11 pending applications·54 citations·filing 2003–2025
88Inventor score
Files withERASMUS UNIV MEDICAL CENTER5SURFACE ONCOLOGY INC5HILL JONATHAN3NOVARTIS AG3SURFACE ONCOLOGY LLC3
Top patents by PatentIndex Score
21 records- 0194US9650441B2Anti-CD47 antibodies and methods of useERASMUS UNIV MEDICAL CENTER·Filed 2016·Granted May 16, 2017·19 cites·20 claims
- 0292US9803016B2Anti-CD47 antibodies and methods of useERASMUS UNIV MEDICAL CENTER·Filed 2017·Granted Oct 31, 2017·11 cites·30 claims
- 0391US11312783B2Antibody molecules to CD73 and uses thereofNOVARTIS AG·Filed 2018·Granted Apr 26, 2022·10 cites·26 claims
- 0487US10570201B2Anti-CD47 antibodies and methods of useERASMUS UNIV MEDICAL CENTER·Filed 2017·Granted Feb 25, 2020·5 cites·39 claims
- 0583US11332524B2Anti-IL-27 antibodies and uses thereofSURFACE ONCOLOGY INC·Filed 2019·Granted May 17, 2022·2 cites·19 claims
- 0668US2020291114A1Anti-cd47 antibodies and methods of useERASMUS UNIV MEDICAL CENTER·Filed 2020·Application pending·0 cites
- 0768US2023039109A1Antibody molecules to cd73 and uses thereofNOVARTIS AG·Filed 2022·Application pending·0 cites
- 0867US2023042258A1Anti-il-27 antibodies and uses thereofSURFACE ONCOLOGY INC·Filed 2022·Application pending·0 cites
- 0965US8198401B2Peptides associated with HLA-DR MHC class II molecule and involved in rheumatoid arthritisHILL JONATHAN·Filed 2004·Granted Jun 12, 2012·3 cites·6 claims
- 1064US2024199732A1Anti-IL-27 Antibodies and Uses ThereofSURFACE ONCOLOGY LLC·Filed 2023·Application pending·0 cites
- 1163US9493539B2Peptides associated with HLA-DR MHC class II molecules involved in autoimmune diseasesHILL JONATHAN·Filed 2004·Granted Nov 15, 2016·2 cites·8 claims
- 1262US10442858B2Anti-CD47 antibodies and methods of useERASMUS UNIV MEDICAL CENTER·Filed 2017·Granted Oct 15, 2019·0 cites·76 claims
- 1360US2025154244A1Anti-il-27 antibodies and uses thereofSURFACE ONCOLOGY LLC·Filed 2025·Application pending·0 cites
- 1459US12358978B2Anti-IL-27 antibodies and uses thereofSURFACE ONCOLOGY LLC·Filed 2019·Granted Jul 15, 2025·0 cites·17 claims
- 1557US2024026001A1Use of anti-il-27 antibodiesSURFACE ONCOLOGY INC·Filed 2023·Application pending·0 cites
- 1657US2024025987A1Use of anti-il-27 antibodiesSURFACE ONCOLOGY INC·Filed 2023·Application pending·0 cites
- 1755US2021115127A1Anti-il-27 antibodies and uses thereofSURFACE ONCOLOGY INC·Filed 2020·Application pending·0 cites
- 1853US7708977B2Method for diagnosis and treatment of vascular diseaseUS HEALTH·Filed 2003·Granted May 4, 2010·2 cites·25 claims
- 1953US2017267740A1Peptides associated with hla-dr mhc class ii molecule and involved in rheumatoid arthritisLONDON HEALTH SCI CT RES INC·Filed 2017·Application pending·0 cites
- 2051US2012225820A1Peptides associated with hla-dr mhc class ii molecule and involved in rheumatoid arthritisHILL JONATHAN·Filed 2012·Application pending·0 cites
- 2144US2021214459A1Antibody molecules to cd73 and uses thereofNOVARTIS AG·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jonathan Hill files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →